OPN-FLU-CS-3205: A 24-week prospective, randomized, double-blind, placebo-controlled, parallel group, multicenter study evaluating the efficacy and safety of intranasal administration of 186 μg and 372 μg of fluticasone propionate twice a day using an exhalation delivery device in adult patients with chronic sinusitis.
Current Project
